A multicenter, randomized, double-blind, placebo-controlled trial evaluating efficacy of adalimumab induction therapy in patients with Crohn's Disease.

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled trial evaluating efficacy of adalimumab induction therapy in patients with Crohn's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jan 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms CLASSIC-I
  • Most Recent Events

    • 03 Jan 2017 New trial record
    • 07 Nov 2016 Results of post hoc analysis of this and other five studies (CLASSIC-I, GAIN, CHARM, EXTEND, ULTRA 1 AND ULTRA 2) published in the Alimentary Pharmacology and Therapeutics
    • 31 Dec 2006 Results published in the GASTROENTEROLOGY 2006.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top